JP2021522172A5 - - Google Patents

Info

Publication number
JP2021522172A5
JP2021522172A5 JP2020557208A JP2020557208A JP2021522172A5 JP 2021522172 A5 JP2021522172 A5 JP 2021522172A5 JP 2020557208 A JP2020557208 A JP 2020557208A JP 2020557208 A JP2020557208 A JP 2020557208A JP 2021522172 A5 JP2021522172 A5 JP 2021522172A5
Authority
JP
Japan
Prior art keywords
seq
item
complex according
peptide complex
peptide
Prior art date
Application number
JP2020557208A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2019209662A5 (https=
JP2021522172A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/028406 external-priority patent/WO2019209662A1/en
Publication of JP2021522172A publication Critical patent/JP2021522172A/ja
Publication of JPWO2019209662A5 publication Critical patent/JPWO2019209662A5/ja
Publication of JP2021522172A5 publication Critical patent/JP2021522172A5/ja
Priority to JP2023213199A priority Critical patent/JP2024019603A/ja
Ceased legal-status Critical Current

Links

JP2020557208A 2018-04-23 2019-04-19 軟骨ホーミングペプチドの複合体 Ceased JP2021522172A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023213199A JP2024019603A (ja) 2018-04-23 2023-12-18 軟骨ホーミングペプチドの複合体

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862661577P 2018-04-23 2018-04-23
US62/661,577 2018-04-23
PCT/US2019/028406 WO2019209662A1 (en) 2018-04-23 2019-04-19 Conjugates of cartilage-homing peptides

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023213199A Division JP2024019603A (ja) 2018-04-23 2023-12-18 軟骨ホーミングペプチドの複合体

Publications (3)

Publication Number Publication Date
JP2021522172A JP2021522172A (ja) 2021-08-30
JPWO2019209662A5 JPWO2019209662A5 (https=) 2022-04-14
JP2021522172A5 true JP2021522172A5 (https=) 2022-04-14

Family

ID=66429652

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020557208A Ceased JP2021522172A (ja) 2018-04-23 2019-04-19 軟骨ホーミングペプチドの複合体
JP2023213199A Pending JP2024019603A (ja) 2018-04-23 2023-12-18 軟骨ホーミングペプチドの複合体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023213199A Pending JP2024019603A (ja) 2018-04-23 2023-12-18 軟骨ホーミングペプチドの複合体

Country Status (6)

Country Link
US (1) US20210252159A1 (https=)
EP (1) EP3784287A1 (https=)
JP (2) JP2021522172A (https=)
AU (1) AU2019261254A1 (https=)
CA (1) CA3097143A1 (https=)
WO (1) WO2019209662A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023079362A1 (en) * 2021-11-03 2023-05-11 Ripple Therapeutics Corporation Processable compositions and use for the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11559580B1 (en) * 2013-09-17 2023-01-24 Blaze Bioscience, Inc. Tissue-homing peptide conjugates and methods of use thereof
US11090358B2 (en) * 2015-09-09 2021-08-17 Fred Hutchinson Cancer Research Center Cartilage-homing peptides
AU2016366668A1 (en) * 2015-12-11 2018-05-31 Fred Hutchinson Cancer Research Center Peptides for renal therapy
AU2018210157B2 (en) * 2017-01-18 2022-10-06 Fred Hutchinson Cancer Center Peptide compositions and methods of use thereof for disrupting TEAD interactions
EP3595699A4 (en) * 2017-03-16 2020-12-23 Blaze Bioscience, Inc. PEPTIDIC CONJUGATES OF CARTILAGE ECOTROPISM AND THEIR METHODS OF USE
CN107137716A (zh) * 2017-05-10 2017-09-08 北京林业大学 一种聚乙二醇偶联环形多肽iRGD和薯蓣皂苷元载药纳米粒子的制备
AU2018283161A1 (en) * 2017-06-15 2020-01-02 Blaze Bioscience, Inc. Renal-homing peptide conjugates and methods of use thereof

Similar Documents

Publication Publication Date Title
US12257326B2 (en) TCO conjugates and methods for delivery of therapeutic agents
JP6622192B2 (ja) 治療薬を局所的送達するための化学構造
EP2994153B1 (de) Peptide und peptid-wirkstoff-konjugate für renales targeting
EP1696932B1 (en) Use of treprostinil to improve kidney functions
JP6297695B2 (ja) 急性骨髄性白血病（ａｍｌ）のための新規併用治療
US10537614B2 (en) Combination preparation including a corticosteroid and exosomes
US20090264392A1 (en) Treating eosinophilic esophagitis
JPH02504630A (ja) ２成分系医薬
TW201720467A (zh) 腎上腺髓素之聚乙二醇基底前藥及其用途
US12157778B2 (en) Peptides for activation of cell signaling in osteoprogenitor cells
Chang et al. Successful treatment of progressive rheumatoid interstitial lung disease with cyclosporine: a case report
US20140329782A1 (en) Combined therapeutic agent
US20210000962A1 (en) Bone fracture repair by targeting of agents that promote bone healing
JP2021522172A5 (https=)
MX2008003067A (es) Composicion que comrpende un dendrimero y el uso del mismo para enlazar fosfato.
JP2011506607A (ja) 免疫炎症性障害の処置のための治療法
CA3123024A1 (en) Compositions and methods for enhancing body weight and lean muscle mass using antagonists against leptin receptor, gdf8 and activin a
JPWO2019209662A5 (https=)
CN101518654B (zh) 一种可携带糖皮质激素作为炎症靶向药物制剂的合成方法
AU2016229906A1 (en) Methods for modulating bone density
US20230382998A1 (en) METHODS FOR TREATING INFLAMMATORY BOWEL DISEASES WITH a4B7 INTEGRIN ANTAGONISTS
JP2015091760A (ja) コラーゲン様ペプチドからなる薬物担体
WO2024006207A1 (en) An n-terminal domain androgen receptor inhibitor and uses thereof
Zhang et al. Annals of Medical Case Reports
CN117940146A (zh) 白细胞特异性细胞穿透分子